Management Of Colorectal Cancer And Diabetes
Caroline Yao, Guy F. Nash, Tamas Hickish
Published 2014 · Medicine
Download PDFAnalyze on Scholarcy
Colorectal cancer is associated with diabetes mellitus and both of these common conditions are often managed together by a surgeon. The surgical focus is usually upon cancer treatment rather than diabetes management. The relationship between colorectal cancer and diabetes is a complex one and can raise problems in both diagnosis and the management of patients with both conditions. This literature review explores the relationship between diabetes, diabetic treatment and colorectal cancer and addresses the issues that arise in diagnosing and treating this patient group. By highlighting these difficulties, this review aims to improve understanding and to provide clearer insight into both surgical and non-surgical management.
This paper references
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Craig J Currie (2009)
Value of a Protective Stoma in Low Anterior Resections for Rectal Cancer
Frank Marusch (2002)
Moving ahead in diabetics' cancer screening; food for thought from the Hellenic experience.
Ioanna Karathanasi (2009)
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
Rudolf J. Kaaks (2000)
Colorectal Cancer Outcomes, Recurrence, and Complications in Persons With and Without Diabetes Mellitus: A Systematic Review and Meta-Analysis
Kelly B. Stein (2009)
Metformin and neoplasia: implications and indications.
Ahmad Aljada (2012)
Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial
Takuma Higurashi (2011)
Functional bowel symptoms in diabetes--the role of autonomic neuropathy.
D. G. Maxton (1991)
History of selected diseases and the risk of colorectal cancer.
Carlo la Vecchia (1991)
A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation
Adil E Bharucha (2012)
Secondary diabetes associated with 5-fluorouracil-based chemotherapy regimens in non-diabetic patients with colorectal cancer: results from a single-centre cohort study.
J-P Feng (2013)
Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes
Zhi-Jiang Zhang (2011)
The role of AMPK/mTOR/S6K1 signaling axis in mediating the physiological process of exercise-induced insulin sensitization in skeletal muscle of C57BL/6 mice.
Xiaolei Liu (2012)
Targeting the AMPK pathway for the treatment of Type 2 diabetes.
Benoit Viollet (2009)
Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
Ahmed N Dehal (2012)
Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals
Hans Jørgen Nielsen (2011)
Long-term comorbidity of diabetes mellitus is a risk factor for perineal wound complications after an abdominoperineal resection
Kenji Matsuda (2008)
Physical activity and survival after colorectal cancer diagnosis.
Jeffrey A. Meyerhardt (2006)
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
Hiroshi Noto (2012)
Colorectal cancer: another complication of diabetes mellitus?
J. C. Ogilvie Will (1998)
Risk Factors for Postoperative Urinary Tract Infection and Urinary Retention in Patients Undergoing Surgery for Colorectal Cancer
Celeste Y. Kang (2012)
Is Diabetes a Risk Factor for Colorectal Cancer?
Hamed Khalili (2012)
Metformin suppresses intestinal polyp growth in ApcMin/+ mice.
Ayako Tomimoto (2008)
Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
Samantha L. Bowker (2006)
Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study.
Kay-Tee Khaw (2004)
Critical aspects in rationale design of fluorouracil-based adjuvant therapies for the management of colon cancer.
V R Sinha (2012)
Adjuvant Therapy in Colon Cancer
Lucia Pereira V. Lombardi (2009)
Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease
Yu-Chung Huang (2010)
Age- and sex-specific risks of colorectal cancers in diabetic patients.
Hua-Fen Chen (2012)
Risk factors for surgical site infections after colorectal resection in diabetic patients.
Rishabh Sehgal (2011)
Risk factors for morbidity and mortality after single-layer continuous suture for ileocolonic anastomosis
Andreas Volk (2010)
Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study
Nada F. Khan (2011)
Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
Robert E. Schoen (2005)
Diseasespecific mortality among stage I-III colorectal cancer Yao et al. 107 patients with diabetes: a large population-based analysis
LV Van de Poll-Franse (2012)
Impaired anal sensation and early diabetic faecal incontinence.
Michael Aitchison (1991)
Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
Chris R. Garrett (2012)
Influencing Factors of Symptomatic Anastomotic Leakage After Anterior Resection of the Rectum for Cancer
Zhi-jie Cong (2009)
Diarrhea and Metformin in a Diabetic Clinic
Paresh Dandona (1983)
Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon
吉田 功 (2007)
The prevalence of chronic diarrhea among diabetic patients
Joseph Lysy (1999)
Impact of obesity on surgical outcomes after colorectal resection.
S Benoist (2000)
Associations Between Colorectal Cancer Screening and Glycemic Control in People With Diabetes, Boston, Massachusetts, 2005-2010
Joanne Wilkinson (2011)
Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men.
Peter T. Campbell (2010)
Risk factors for anastomotic leak and mortality in diabetic patients undergoing colectomy: analysis from a statewide surgical quality collaborative.
Matthew A. Ziegler (2012)
Metformin and reduced risk of cancer in diabetic patients
Josie M. M. Evans (2005)
Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition.
Mazda Jenab (2007)
Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature.
Lars Budäus (2012)
Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis.
Davide Soranna (2012)
Impact of diabetes mellitus on outcomes in patients with colon cancer.
Jeffrey A. Meyerhardt (2003)
Clinical Challenges in Caring for Patients With Diabetes and Cancer
Helen M. Psarakis (2006)
Screening for colorectal cancer: possible improvements by risk assessment evaluation?
Hans Jørgen Nielsen (2011)
Impairment of anorectal function in diabetes mellitus parallels duration of disease
Emmanuel Epanomeritakis (1999)
Diabetes mellitus among cancer survivors
Charles J. Stava (2007)
Disease-specific mortality among stage I–III colorectal cancer patients with diabetes: a large population-based analysis
Lonneke V van de Poll-Franse (2012)
Diabetes Mellitus and the Incidence of Colorectal Cancer: An Updated Systematic Review and Meta-Analysis
Longying Deng (2012)
Pre-operative carbohydrate loading may be used in type 2 diabetes patients.
Ulf O Gustafsson (2008)
This paper is referenced by
Clinical question : Treatment early rectal cancer
Molecular evidence of field cancerization initiated by diabetes in colon cancer patients
Laura del Puerto‐Nevado (2019)
Mechanisms of action of therapeutic antibodies for cancer.
Jason M. Redman (2015)